Search company, investor...
MedRespond company logo



Seed | Alive

Total Raised


Last Raised

$50K | 2 yrs ago

About MedRespond

MedRespond is a Healthcare/Medical Facilities & Services company based in Pittsburgh, Pennsylvania. MedRespond has received investment from Pittsburgh Life Sciences Greenhouse.

Headquarters Location

76 South 21st Street

Pittsburgh, Pennsylvania, 15203,

United States


Missing: MedRespond's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: MedRespond's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

MedRespond Patents

MedRespond has filed 1 patent.

The 3 most popular patent topics include:

  • Health informatics
  • Videotelephony
  • Artificial neural networks
patents chart

Application Date

Grant Date


Related Topics




Videotelephony, Natural language processing, Artificial neural networks, Health informatics, Units of information


Application Date


Grant Date



Related Topics

Videotelephony, Natural language processing, Artificial neural networks, Health informatics, Units of information



Latest MedRespond News

My Vaccine Program (MVP) Combines Best-of-Breed Technologies to Address Consumer Engagement, Vaccine Hesitancy and Safety Surveillance Related to COVID-19

Apr 19, 2021

As COVID vaccine safety-related issues escalate, stakeholders implement digital strategies to communicate to leery consumers the risks/benefits of vaccination. April 19, 2021 12:01 AM Eastern Daylight Time ROCKVILLE, Md.--( BUSINESS WIRE )-- MediMergent - The Real-World Evidence Company, in collaboration with MedRespond , an AI-driven Conversational Technology company and TalkBackTime , a video-based consumer engagement company, launch My Vaccine Program (MVP), a fully-integrated, cloud-based platform that engages and educates consumers related to their COVID-19 vaccine experiences. Sandra Garrett, CEO of MediMergent states: “The MVP engages directly with consumers and captures their attitudes and behaviors related to their health/disease and treatment, in order to improve outcomes. To address vaccine hesitancy, consumers need accurate information regarding the risks/benefits and how people “just like me”, with similar health profiles, react to the vaccine. The MVP builds a supportive community, especially for the medically underserved and ethnic and racial minorities.” “Deploying a library of over 250 learning modules, we invite patients to open a dialogue with a virtual healthcare expert”, says Virginia Pribanic, CEO of MedRespond. “The platform anticipates questions using AI-based algorithms and delivers personalized, patient-centered responses. We explore vaccine hesitancy, validate patients’ concerns, and present a fact-based discussion supporting the patients’ decision making.” TalkBackTime obtains consumer feedback on pre-defined issues like vaccine hesitancy, and produces candid videos which resonate with “people like me” through actual speech patterns, dialects, tone, mode and body language. “Our analytics profile responses by age, sex, race, ethnicity, location” says Allan Horlick, Managing Partner. “These videos add a qualitative dimension to the quantitative data we are collecting in the MVP”. Consumers enroll in the My Vaccine Program and complete surveys, across eight weeks, about their vaccine experiences. They enroll in the program via an application to their administering pharmacy, vaccination center, or their employee health and wellness programs. MediMergent’s platform monitors post-vaccination safety surveillance, tracks potential side effects and produces de-identified data that can be reported to multiple stakeholders, including the consumers themselves. These multi-faceted engagements empower consumers with relevant data, within their own community, enabling them to move from hesitancy to vaccination. Contacts

MedRespond Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

MedRespond Rank

MedRespond Frequently Asked Questions (FAQ)

  • Where is MedRespond's headquarters?

    MedRespond's headquarters is located at 76 South 21st Street, Pittsburgh.

  • What is MedRespond's latest funding round?

    MedRespond's latest funding round is Seed.

  • How much did MedRespond raise?

    MedRespond raised a total of $270K.

  • Who are the investors of MedRespond?

    Investors of MedRespond include Innovation Works and Pittsburgh Life Sciences Greenhouse.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.